Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Medical Facilities CorporationTSX: DR.TO

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables dips below year-ago levels

Q1 FY2026 accounts payables of $936.4K (cash outflow) fell 73.5% year over year, behind the +349.5% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -8.9% a year.

Context

  • Accounts payables amounted to 0.7% of revenue in FY2025, up 0.6 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -73.5% toward the trailing-twelve-month pace of +349.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$936.4K-124.6% QoQ
Last fiscal yearDec 2025
$1.86M+475.8% YoY
LTMMar 2026
$4.49M+349.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-73.5%——
1 year+475.8%——
3-year CAGR-8.9%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
1.86M USD
Year-over-year change
+475.8%

Accounts Payables vs competitors

How DR.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +349.5% is the 2nd highest of 8, against a peer median of -71.9%.
  • Accounts payables amounts to 1.5% of revenue for DR.TO, versus a peer median of 1.5%.
DR.TO Competitors
Accounts Payables for DR.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$6.02M CAD-234.6%—3.8%
CRRX.TOCareRx CorporationLTM Mar 2026CA$5.6M CAD-185.0%—1.5%
DR.TOMedical Facilities CorporationLTM Mar 2026$4.49M USD+349.5%-8.9%1.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$4.35M CAD-71.9%—1.4%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$3.31M USD+279.8%+22.0%—
TSND.TOTerrAscend Corp.LTM Mar 2026$3.14M USD-22.4%-33.7%1.2%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$973.33K USD+1180.7%-4.7%1.9%
PRN.TOProfound Medical Corp.LTM Mar 2026$379.28K USD-77.5%—2.0%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding DR.TO) —-71.9%-4.7%1.5%

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income46.49M12.3M44M105.56M21.08M
Depreciation & Amortization26.77M20.76M21.54M19.37M15.66M
Deferred Income Tax4.4M5.21M8.33M(3.67M)6.01M
Stock-Based Compensation292K(667K)(397K)(246K)0
Change in Working Capital(10.45M)(6.21M)(488K)(1.64M)(3.96M)
Accounts Receivables(1.23M)(2.6M)1.03M5.23M(4.02M)
Inventory659K1.42M(205K)(476K)(659.34K)
Accounts Payables(525K)2.46M(2.48M)(495K)1.86M
Other Working Capital(9.35M)(7.5M)1.17M(5.9M)(1.14M)
Other Non-Cash Items8.14M25.63M(183K)(36.09M)7.16M
Operating Cash Flow75.64M57.01M72.71M83.28M45.95M
Capital Expenditures(8.42M)(6.72M)(16.05M)(7.07M)(4.96M)
Acquisitions (Net)(267K)943K2.39M92.49M826.21K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(267K)943K2.39M00
Investing Cash Flow(8.69M)(5.78M)(13.67M)85.42M(4.14M)
Debt Repayment(30.05M)(6.47M)(28.84M)(32.82M)(2.62M)
Common Stock Issued00000
Common Stock Repurchased(2.07M)(38.38M)(7.42M)(16.61M)(64.78M)
Dividends Paid(6.92M)(7.5M)(6.07M)(6.1M)(5.18M)
Other Financing Activities(33.02M)(25M)(27.49M)(28.73M)(34.72M)
Financing Cash Flow(72.06M)(77.35M)(69.83M)(84.26M)(107.3M)
Effect of Forex Changes(34K)(3K)(34K)(59K)(4.77M)
Net Change in Cash(5.14M)(26.12M)(10.81M)84.38M(70.26M)
Free Cash Flow67.22M50.3M56.66M76.22M40.99M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.